Literature DB >> 3488860

In situ characterization of the cell-surface antigens of the mononuclear cell infiltrate and bile duct epithelium in primary biliary cirrhosis.

G Colucci, F Schaffner, F Paronetto.   

Abstract

To analyze the tissue distribution of mononuclear cells and HLA antigens in primary biliary cirrhosis, we studied liver biopsies of 12 patients at different stages of the disease, using the avidin-biotin-peroxidase technique and monoclonal antibodies directed against T and B lymphocytes, T-cell subsets, macrophages, NK/K cells, dendritic cells, and HLA class I and II antigens. To evaluate the proportion of activated T cells we used anti-interleukin-2-receptor antibodies and a double-staining technique for T cells and class II HLA antigens. In all biopsies activated T cells predominated in the portal areas and around the damaged bile ducts. T4 cells almost always outnumbered T8 cells. While B cells, NK/K cells, and dendritic cells were always scarce, macrophages constituted about 30% of the cellular infiltrate. Biliary epithelium, which normally expresses HLA class I antigens, displayed mainly HLA class II antigens. The predominance of T4 cells around the bile ducts, which express class II antigens, suggests that class II-restricted T4 lymphocytes may mediate liver damage in primary biliary cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3488860     DOI: 10.1016/0090-1229(86)90049-8

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  11 in total

1.  Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis.

Authors:  Hiroto Kita; Shuji Matsumura; Xiao-Song He; Aftab A Ansari; Zhe-Xiong Lian; Judy Van de Water; Ross L Coppel; Marshall M Kaplan; M Eric Gershwin
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

2.  Serum interferon-gamma-inducing factor/IL-18 levels in primary biliary cirrhosis.

Authors:  T Yamano; T Higashi; K Nouso; H Nakatsukasa; K Kariyama; E Yumoto; Y Kobayashi; K Yamamoto; H Iwagaki; T Yagi; T Tanimoto; M Kurimoto; N Tanaka; T Tsuji
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

Review 3.  Primary biliary cirrhosis: From bench to bedside.

Authors:  Elias Kouroumalis; George Notas
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-08-06

Review 4.  Primary biliary cirrhosis: considerations on pathogenesis based on identification of the M2 autoantigens.

Authors:  I R Mackay; M E Gershwin
Journal:  Springer Semin Immunopathol       Date:  1990

Review 5.  Pathogenesis of primary biliary cirrhosis: a unifying model.

Authors:  Elias Kouroumalis; George Notas
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

6.  Histologic studies on the hepatic lesions induced by graft-versus-host reaction in MHC class II disparate hosts compared with primary biliary cirrhosis.

Authors:  T Saitoh; M Fujiwara; M Nomoto; T Kamimura; K Ishihara; H Asakura
Journal:  Am J Pathol       Date:  1989-08       Impact factor: 4.307

7.  Primary biliary cirrhosis: seeking the silent partner of autoimmunity.

Authors:  I Sutton; J Neuberger
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

8.  S100 protein positive dendritic cells in primary biliary cirrhosis and other chronic inflammatory liver diseases. Relevance to pathogenesis?

Authors:  A J Demetris; C Sever; S Kakizoe; S Oguma; T E Starzl; R Jaffe
Journal:  Am J Pathol       Date:  1989-04       Impact factor: 4.307

9.  Defective proliferation and regulatory function of CD4+ T cells bearing Leu-8 homing receptor in primary biliary cirrhosis. Phorbol myristate acetate enhances T-cell function.

Authors:  R Moreno-Otero; Y Murakawa; M E Kanof; M P Civeira; E A Jones; S P James
Journal:  Dig Dis Sci       Date:  1994-06       Impact factor: 3.199

10.  Identification of HLA-A2-restricted CD8(+) cytotoxic T cell responses in primary biliary cirrhosis: T cell activation is augmented by immune complexes cross-presented by dendritic cells.

Authors:  Hiroto Kita; Zhe-Xiong Lian; Judy Van de Water; Xiao-Song He; Shuji Matsumura; Marshall Kaplan; Velimir Luketic; Ross L Coppel; Aftab A Ansari; M Eric Gershwin
Journal:  J Exp Med       Date:  2002-01-07       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.